Notice for glofitamab (Roche Products Pty Limited)
Active ingredients
glofitamab
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Indication
Treatment of diffuse large B-cell lymphoma
Therapeutic area
Haematology